1. Katiyar, SK & Mukhtar, H (1997) Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl 27, 59–67.
2. Junqueira, VB, Barros, SB, Chan, SS, et al. (2004) Aging and oxidative stress. Mol Aspects Med 25, 5–16.
3. Roncevic, M (2007) Encyclopedia of stress. Libr J 132, 104–107.
4. Vaziri, ND & Rodriguez-Iturbe, B (2006) Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2, 582–593.
5. Kryston, TB, Georgiev, AB, Pissis, P, et al. (2011) Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 711, 193–201.
6. Reuter, S, Gupta, SC, Chaturvedi, MM, et al. (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49, 1603–1616.
7. Coluzzi, E, Colamartino, M, Cozzi, R, et al. (2014) Oxidative stress induces persistent telomeric DNA damage responsible for nuclear morphology change in mammalian cells. PLOS ONE 9, e110963.
8. Sosa, V, Moline, T, Somoza, R, et al. (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12, 376–390.
9. Nunomura, A, Castellani, RJ, Zhu, X, et al. (2006) Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65, 631–641.
10. Wu, Y, Tang, L & Chen, B (2014) Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Oxid Med Cell Longev 2014, 752387.
11. Milne, GL, Musiek, ES & Morrow, JD (2005) F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10, Suppl. 1, S10–S23.
12. Dorjgochoo, T, Gao, YT, Chow, WH, et al. (2012) Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself. Am J Clin Nutr 96, 405–414.
13. Van’t Erve, TJ, Lih, FB, Jelsema, C, et al. (2016) Reinterpreting the best biomarker of oxidative stress: the 8-iso-prostaglandin F2alpha/prostaglandin F2alpha ratio shows complex origins of lipid peroxidation biomarkers in animal models. Free Radic Biol Med 95, 65–73.
14. Rossner, P Jr, Gammon, MD, Terry, MB, et al. (2006) Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15, 639–644.
15. Schwedhelm, E, Bartling, A, Lenzen, H, et al. (2004) Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case–control study. Circulation 109, 843–848.
16. van ‘t Erve, TJ, Kadiiska, MB, London, SJ, et al. (2017) Classifying oxidative stress by F2-isoprostane levels across human diseases: a meta-analysis. Redox Biol 12, 582–599.
17. Lin, JK, Liang, YC & Lin-Shiau, SY (1999) Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol 58, 911–915.
18. Yang, WS, Wang, WY, Fan, WY, et al. (2014) Tea consumption and risk of type 2 diabetes: a dose–response meta-analysis of cohort studies. Br J Nutr 111, 1329–1339.
19. Lambert, JD (2013) Does tea prevent cancer? Evidence from laboratory and human intervention studies. Am J Clin Nutr 98, 1667S–1675S.
20. Arab, L, Khan, F & Lam, H (2013) Tea consumption and cardiovascular disease risk. Am J Clin Nutr 98, 1651S–1659S.
21. Chen, D, Wan, SB, Yang, H, et al. (2011) EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem 53, 155–177.
22. Scalbert, A, Johnson, IT & Saltmarsh, M (2005) Polyphenols: antioxidants and beyond. Am J Clin Nutr 81, 215S–217S.
23. Cavet, ME, Harrington, KL, Vollmer, TR, et al. (2011) Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Mol Vis 17, 533–542.
24. Tipoe, GL, Leung, TM, Hung, MW, et al. (2007) Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 7, 135–144.
25. Basu, A, Sanchez, K, Leyva, MJ, et al. (2010) Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr 29, 31–40.
26. Bogdanski, P, Suliburska, J, Szulinska, M, et al. (2012) Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res 32, 421–427.
27. Klaunig, JE, Xu, Y, Han, C, et al. (1999) The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med 220, 249–254.
28. Hakim, IAGL, Harris, R, Cordova, CA, et al. (2017) Modulation of oxidative damage by green and black tea: role of smoking and gender in a randomized trial. J Nutr Food Sci 7, 633.
29. Sandler, DP, Hodgson, ME, Deming-Halverson, SL, et al. (2017) The Sister Study cohort: baseline methods and participant characteristics. Environ Health Perspect 125, 127003.
30. Parks, CG, Miller, DB, McCanlies, EC, et al. (2009) Telomere length, current perceived stress, and urinary stress hormones in women. Cancer Epidemiol Biomarkers Prev 18, 551–560.
31. Milne, GL, Sanchez, SC, Musiek, ES, et al. (2007) Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2, 221–226.
32. Morrow, JD & Roberts, LJ 2nd (1999) Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 300, 3–12.
33. Morales, CR, Terry, ES, Zackert, WE, et al. (2001) Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay. Clin Chim Acta 314, 93–99.
34. Milne, GL, Gao, B, Terry, ES, et al. (2013) Measurement of F2-isoprostanes and isofurans using gas chromatography–mass spectrometry. Free Radic Biol Med 59, 36–44.
35. Anderson, C, Milne, GL, Sandler, DP, et al. (2016) Oxidative stress in relation to diet and physical activity among premenopausal women. Br J Nutr 116, 1416–1424.
36. Lin, CJ, DeRoo, LA, Jacobs, SR, et al. (2012) Accuracy and reliability of self-reported weight and height in the Sister Study. Public Health Nutr 15, 989–999.
37. Block, G, Hartman, AM, Dresser, CM, et al. (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124, 453–469.
39. Mitchell, DC, Knight, CA, Hockenberry, J, et al. (2014) Beverage caffeine intakes in the US. Food Chem Toxicol 63, 136–142.
41. Ainsworth, B (2002) The Compendium of Physical Activities Tracking Guide. Columbia, SC: Prevention Research Center, Norman J Arnold School of Public Health, University of South Carolina.
42. Craig, CL, Marshall, AL, Sjostrom, M, et al. (2003) International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35, 1381–1395.
44. Willett, WC, Howe, GR & Kushi, LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65, 1220S–1228S; discussion 1229S–1231S.
45. Devasagayam, TP, Kamat, JP, Mohan, H, et al. (1996) Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta 1282, 63–70.
46. Shi, X, Dalal, NS & Jain, AC (1991) Antioxidant behaviour of caffeine: efficient scavenging of hydroxyl radicals. Food Chem Toxicol 29, 1–6.
47. Nikitina, D, Chen, Z, Vallis, K, et al. (2015) Relationship between caffeine and levels of DNA repair and oxidative stress in women with and without a BRCA1 mutation. J Nutrigenet Nutrigenomics 8, 174–184.
48. Rothman, KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1, 43–46.
49. Savitz, DA & Olshan, AF (1998) Describing data requires no adjustment for multiple comparisons: a reply from Savitz and Olshan. Am J Epidemiol 147, 813–814; discussion 815.
50. Stote, KS, Clevidence, BA, Novotny, JA, et al. (2012) Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance. Eur J Clin Nutr 66, 1153–1159.
51. Henning, SM, Niu, Y, Lee, NH, et al. (2004) Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 80, 1558–1564.
52. Stoner, GD & Mukhtar, H (1995) Polyphenols as cancer chemopreventive agents. J Cell Biochem 22, 169–180.
53. Lee, KW, Lee, HJ & Lee, CY (2002) Antioxidant activity of black tea v. green tea. J Nutr 132, 785; author reply 786.
54. Lee, KW, Lee, HJ & Lee, CY (2002) Antioxidant activity of black tea v. green tea. J Nutr 132, 785.
55. Rains, TM, Agarwal, S & Maki, KC (2011) Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22, 1–7.
56. Sinha, RA, Farah, BL, Singh, BK, et al. (2014) Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology 59, 1366–1380.
57. Olcina, GJ, Timon, R, Munoz, D, et al. (2008) Caffeine ingestion effects on oxidative stress in a steady-state test at 75% V-O2 (max). Sci Sport 23, 87–90.
58. Metro, D, Cernaro, V, Santoro, D, et al. (2017) Beneficial effects of oral pure caffeine on oxidative stress. J Clin Transl Endocrinol 10, 22–27.
59. Zeraatpishe, A, Malekirad, AA, Nik-Kherad, J, et al. (2015) The effects of caffeine supplements on exercise-induced oxidative damages. Asian J Sports Med 6, e23023.
60. Richelle, M, Turini, ME, Guidoux, R, et al. (1999) Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett 459, 259–262.
61. Janero, DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9, 515–540.
62. Il’yasova, D, Scarbrough, P & Spasojevic, I (2012) Urinary biomarkers of oxidative status. Clin Chim Acta 413, 1446–1453.
63. Helmersson, J & Basu, S (1999) F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukotrienes Essent Fatty Acids 61, 203–205.
64. Sabatini, L, Barbieri, A, Tosi, M, et al. (2005) A method for routine quantitation of urinary 8-hydroxy-2′-deoxyguanosine based on solid-phase extraction and micro-high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 19, 147–152.
65. Pilger, A, Ivancsits, S, Germadnik, D, et al. (2002) Urinary excretion of 8-hydroxy-2′-deoxyguanosine measured by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci 778, 393–401.